Prednisone and Prostatic specific antigen decreased - a phase IV clinical study of FDA data

Summary:

Prostatic specific antigen decreased is reported as a side effect among people who take Prednisone (prednisone), especially for people who are 60+ old, have been taking the drug for 1 - 6 months also take Zytiga, and have Prostate cancer.

The phase IV clinical study analyzes which people have Prostatic specific antigen decreased when taking Prednisone. It is created by eHealthMe based on reports of 628,814 people who have side effects when taking Prednisone from the FDA, and is updated regularly.

What is Prednisone?

Prednisone has active ingredients of prednisone. It is often used in rheumatoid arthritis. eHealthMe is studying from 636,827 Prednisone users. Check the latest studies of Prednisone.

What is Prostatic specific antigen decreased?

Prostatic specific antigen decreased is found to be associated with 37 drugs and 110 conditions by eHealthMe. Check the latest studies of Prostatic specific antigen decreased.

On Aug, 02, 2026

628,814 people reported to have side effects when taking Prednisone.
Among them, 15 people (0.0%) have Prostatic specific antigen decreased.

Could Prednisone cause Prostatic specific antigen decreased?

Among these 15 people:

How long have people been on Prednisone when they have Prostatic specific antigen decreased? *

What is the age of people who have Prostatic specific antigen decreased when taking Prednisone? *

What are other drugs people take besides Prednisone? *

What are other side effects people have besides Prostatic specific antigen decreased? *

Fatigue (feeling of tiredness): 5 people, 33.33%
Urinary Tract Infection: 3 people, 20.00%
Haemoglobin Decreased: 3 people, 20.00%
Red Blood Cell Count Decreased: 3 people, 20.00%
Haematocrit Decreased: 3 people, 20.00%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 2 people, 13.33%
Metastases To Bone (cancer spreads to bone): 2 people, 13.33%
Dehydration (dryness resulting from the removal of water): 2 people, 13.33%
Muscle Atrophy (a decrease in the mass of the muscle): 2 people, 13.33%
Blood Calcium Decreased: 2 people, 13.33%

What are the existing conditions these people have? *

Prostate Cancer: 9 people, 60.00%
Prostate Cancer Metastatic: 5 people, 33.33%
Malignant Neoplasm Progression (cancer tumour came back): 2 people, 13.33%
Nausea (feeling of having an urge to vomit): 2 people, 13.33%
High Blood Cholesterol: 2 people, 13.33%
Arrhythmias (irregular heartbeat): 2 people, 13.33%
Neoplasm Malignant (cancer tumour): 1 person, 6.67%
Hormone Level Abnormal: 1 person, 6.67%
Arterial Disorder: 1 person, 6.67%
Blood Pressure Abnormal: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Prednisone and have Prostatic specific antigen decreased?

- Check whether Prostatic specific antigen decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Prednisone:

Prednisone (636,827 reports)

Browse all side effects of Prednisone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Prostatic specific antigen decreased:

Prostatic specific antigen decreased (37 drugs)

Browse all the conditions that are associated with Prostatic specific antigen decreased:

Prostatic specific antigen decreased (110 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on prednisone (the active ingredients of Prednisone) and Prednisone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.